BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 132 filers reported holding BRIDGEBIO PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,529,730 | -34.0% | 476,180 | -73.7% | 2.47% | -50.2% |
| Q2 2023 | $31,123,159 | +64.0% | 1,809,486 | +58.1% | 4.96% | +15.1% |
| Q1 2023 | $18,972,262 | +944.2% | 1,144,286 | +472.1% | 4.30% | +1200.6% |
| Q2 2022 | $1,817,000 | -89.2% | 200,000 | -80.2% | 0.33% | -86.8% |
| Q4 2021 | $16,866,000 | +1542.3% | 1,011,200 | +3110.2% | 2.51% | +2963.4% |
| Q2 2020 | $1,027,000 | -59.7% | 31,500 | -64.2% | 0.08% | -57.3% |
| Q1 2020 | $2,549,000 | – | 87,900 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
| M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
| Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
| HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
| Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
| Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
| Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
| HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |